Abstract
We report the successful and maintained response of lymphomatoid granulomatosis using a new approach to therapy, cyclosporin-A, after failure of aggressive multiagent chemotherapy.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
CD4-Positive T-Lymphocytes / drug effects
-
CD4-Positive T-Lymphocytes / pathology
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Cyclosporine / pharmacology
-
Cyclosporine / therapeutic use*
-
Doxorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Humans
-
Immunosuppressive Agents / pharmacology
-
Immunosuppressive Agents / therapeutic use*
-
Lung Diseases / diagnosis
-
Lung Diseases / drug therapy
-
Lung Diseases / pathology
-
Lung Diseases / therapy*
-
Lymphomatoid Granulomatosis / diagnosis
-
Lymphomatoid Granulomatosis / drug therapy
-
Lymphomatoid Granulomatosis / pathology
-
Lymphomatoid Granulomatosis / therapy*
-
Male
-
Mechlorethamine / administration & dosage
-
Methotrexate / administration & dosage
-
Middle Aged
-
Prednisone / administration & dosage
-
Procarbazine / administration & dosage
-
Recurrence
-
Remission Induction
-
Salvage Therapy
-
Vincristine / administration & dosage
Substances
-
Immunosuppressive Agents
-
Procarbazine
-
Mechlorethamine
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Cyclosporine
-
Cyclophosphamide
-
Prednisone
-
Methotrexate